Thalidomine USP26
Brand names,
Thalidomine USP26
Analogs
Thalidomine USP26
Brand Names Mixture
Thalidomine USP26
Chemical_Formula
C16H13Cl3N2OS
Thalidomine USP26
RX_link
http://www.rxlist.com/cgi/generic3/tioconaz.htm
Thalidomine USP26
fda sheet
Thalidomine USP26
msds (material safety sheet)
Thalidomine USP26
Synthesis Reference
No information avaliable
Thalidomine USP26
Molecular Weight
387.711 g/mol
Thalidomine USP26
Melting Point
No information avaliable
Thalidomine USP26
H2O Solubility
No information avaliable
Thalidomine USP26
State
Solid
Thalidomine USP26
LogP
4.971
Thalidomine USP26
Dosage Forms
Cream; Ointment; Suppository (each applicator-full provides approximately 4.6 grams of ointment containing 300 mg of tioconazole)
Thalidomine USP26
Indication
For the local treatment of vulvovaginal candidiasis (moniliasis).
Thalidomine USP26
Pharmacology
Tioconazole is a broad-spectrum imidazole antifungal agent that inhibits the growth of human pathogenic yeasts. Tioconazole exhibits fungicidal activity in vitro against Candida albicans, other species of the genus Candida, and against Torulopsis glabrata. Tioconazole prevents the growth and function of some fungal organisms by interfering with the production of substances needed to preserve the cell membrane. This drug is effective only for infections caused by fungal organisms. It will not work for bacterial or viral infections.
Thalidomine USP26
Absorption
Systemic absorption following a single intravaginal application of tioconazole in nonpregnant patients is negligible.
Thalidomine USP26
side effects and Toxicity
Symptoms of overdose include erythema, stinging, blistering, peeling, edema, pruritus, urticaria, burning,
Thalidomine USP26
Patient Information
Thalidomine USP26
Organisms Affected
Yeast and other fungi